Henry F. Chambers - Publications

Affiliations: 
Medicine University of California, San Francisco, San Francisco, CA 
Area:
Staphylococcus aureus

207 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Lai LY, Satishkumar N, Cardozo S, Hemmadi V, Marques LB, Huang L, Filipe SR, Pinho MG, Chambers HF, Chatterjee SS. Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in . Biorxiv : the Preprint Server For Biology. PMID 37961375 DOI: 10.1101/2023.10.26.564222  0.396
2023 Chambers HF, Cross HR, Souli M, Evans SR, Patel R, Fowler VG. The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 77: S279-S287. PMID 37843121 DOI: 10.1093/cid/ciad475  0.355
2023 Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J, Cober E, Alenazi T, Zong Z, Xie Q, Liu Z, Li L, Yu Y, Gao H, Kanj SS, ... ... Chambers HF, et al. Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Acinetobacter baumannii Among Patients from Different Global Regions. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37738153 DOI: 10.1093/cid/ciad556  0.341
2023 Fan SH, Proctor RA, Ersoy SC, Manna AC, Cheung AL, Götz F, Chambers HF, Bayer AS. Role of the NaHCO Transporter MpsABC in the NaHCO-β-Lactam-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureus. Microbiology Spectrum. e0014123. PMID 37102972 DOI: 10.1128/spectrum.00141-23  0.327
2022 Tamma PD, Komarow L, Ge L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade E, Miller LG, Jacob JT, Satlin MJ, Krsak M, Huskins WC, Dhar S, ... ... Chambers HF, et al. Clinical Impact of Ceftriaxone Resistance in Bloodstream Infections: A Multicenter Prospective Cohort Study. Open Forum Infectious Diseases. 9: ofac572. PMID 36381622 DOI: 10.1093/ofid/ofac572  0.355
2022 Ersoy SC, Gonçalves B, Cavaco G, Manna AC, Sobral RG, Nast CC, Proctor RA, Chambers HF, Cheung A, Bayer AS. Influence of Sodium Bicarbonate on Wall Teichoic Acid Synthesis and β-Lactam Sensitization in NaHCO-Responsive and Nonresponsive Methicillin-Resistant Staphylococcus aureus. Microbiology Spectrum. e0342222. PMID 36377886 DOI: 10.1128/spectrum.03422-22  0.347
2022 Chambers HF, Fowler VG. Confronting Antimicrobial Resistance Together. American Journal of Physiology. Lung Cellular and Molecular Physiology. PMID 36193938 DOI: 10.1152/ajplung.00327.2022  0.34
2021 Wang M, Earley M, Chen L, Hanson BM, Yu Y, Liu Z, Salcedo S, Cober E, Li L, Kanj SS, Gao H, Munita JM, Ordoñez K, Weston G, Satlin MJ, ... ... Chambers HF, et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. The Lancet. Infectious Diseases. PMID 34767753 DOI: 10.1016/S1473-3099(21)00399-6  0.333
2021 Chambers HF, Evans SR, Patel R, Cross HR, Harris AD, Doi Y, Boucher HW, van Duin D, Tsalik EL, Holland TL, Pettigrew MM, Tamma PD, Hodges KR, Souli M, Fowler VG. Antibacterial Resistance Leadership Group 2.0 - Back to Business. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33588438 DOI: 10.1093/cid/ciab141  0.303
2020 Chambers HF, Bayer AS. Native-Valve Infective Endocarditis. The New England Journal of Medicine. 383: 567-576. PMID 32757525 DOI: 10.1056/Nejmcp2000400  0.326
2020 Raphael E, Chambers HF. Differential Trends in Extended-Spectrum Beta-Lactamase-Producing Infections in Four Health Care Facilities in a Single Metropolitan Area: A Retrospective Analysis. Microbial Drug Resistance (Larchmont, N.Y.). PMID 32589493 DOI: 10.1089/Mdr.2020.0058  0.375
2020 Alexander JAN, Radaeva M, King DT, Chambers HF, Cherkasov A, Chatterjee SS, Strynadka NCJ. -Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant . The Journal of Biological Chemistry. PMID 32518158 DOI: 10.1074/Jbc.Ra120.013029  0.41
2020 Lodise TP, Smith NM, O'Donnell N, Eakin AE, Holden PN, Boissonneault KR, Zhou J, Tao X, Bulitta JB, Fowler VG, Chambers HF, Bonomo RA, Tsuji BT. Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model. The Journal of Antimicrobial Chemotherapy. PMID 32464664 DOI: 10.1093/Jac/Dkaa197  0.373
2020 Spellberg B, Chambers HF, Musher DM, Walsh TL, Bayer AS. Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative Review. Jama Internal Medicine. PMID 32227127 DOI: 10.1001/Jamainternmed.2020.0555  0.409
2020 van Duin D, Arias CA, Komarow L, Chen L, Hanson BM, Weston G, Cober E, Garner OB, Jacob JT, Satlin MJ, Fries BC, Garcia-Diaz J, Doi Y, Dhar S, Kaye KS, ... ... Chambers HF, et al. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. The Lancet. Infectious Diseases. PMID 32151332 DOI: 10.1016/S1473-3099(19)30755-8  0.385
2020 Ersoy SC, Otmishi M, Milan VT, Li L, Pak Y, Mediavilla J, Chen L, Kreiswirth B, Chambers HF, Proctor RA, Xiong YQ, Fowler VG, Bayer AS. Scope and Predictive Genetic/Phenotypic Signatures of 'Bicarbonate [NaHCO]-Responsiveness' and β-Lactam Sensitization Among Methicillin-Resistant (MRSA). Antimicrobial Agents and Chemotherapy. PMID 32041719 DOI: 10.1128/Aac.02445-19  0.382
2019 Rose WE, Bienvenida AM, Xiong YQ, Chambers HF, Bayer AS, Ersoy SC. Ability of Bicarbonate Supplementation to Sensitize Selected Methicillin-Resistant (MRSA) Strains to β-Lactam Antibiotics in an Simulated Endocardial Vegetation Model. Antimicrobial Agents and Chemotherapy. PMID 31844004 DOI: 10.1128/Aac.02072-19  0.423
2019 Doernberg SB, Komarow L, Tran TTT, Sund Z, Pandori MW, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JD. Simultaneous Evaluation of Diagnostic Assays for Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis Using a Master Protocol. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31734695 DOI: 10.1093/Cid/Ciz1105  0.356
2019 Kalil AC, Holubar M, Deresinski S, Chambers HF. Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia? Antimicrobial Agents and Chemotherapy. 63. PMID 31640977 DOI: 10.1128/Aac.00900-19  0.32
2019 Wilson B, Viau R, Perez F, Jiang H, Fowler VG, Chambers HF, Kreiswirth BN, Bonomo RA, Evans SR. Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia. Open Forum Infectious Diseases. 6: ofz267. PMID 31290855 DOI: 10.1093/Ofid/Ofz267  0.376
2019 Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, ... ... Chambers H, et al. The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31157370 DOI: 10.1093/Cid/Ciz460  0.342
2019 Gutierrez J, Guimaraes AO, Lewin-Koh N, Berhanu A, Xu M, Cao Y, Kim J, Yan D, Chang JK, Dinoso JB, Koss CA, Clemenzi-Allen A, Chambers HF, Peck MC, Baruch A, et al. Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Bacteremia. Open Forum Infectious Diseases. 6: ofz090. PMID 31024970 DOI: 10.1093/Ofid/Ofz090  0.35
2019 Ersoy SC, Abdelhady W, Li L, Chambers HF, Xiong YQ, Bayer AS. Bicarbonate Resensitization of Methicillin-Resistant to β-Lactam Antibiotics. Antimicrobial Agents and Chemotherapy. PMID 31010857 DOI: 10.1128/Aac.00496-19  0.498
2019 Liu C, Strnad L, Beekmann SE, Polgreen PM, Chambers HF. Clinical Practice Variation Among Adult Infectious Diseases Physicians in the Management of Staphylococcus aureus Bacteremia. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30601989 DOI: 10.1093/Cid/Ciy1144  0.308
2019 Reyes J, Diaz L, Carvajal LP, Rios R, Millan LV, Echeverri AM, Hernandez AK, Vargas S, Salcedo S, Marin A, Mora L, Ordonez Diaz KM, Cristancho Quintero E, Valderrama S, Elena Ariza B, ... ... Chambers HF, et al. 625. Genomic Epidemiology of Carbapenem-Resistant Enterobacteriaceae from Colombia: A Prospective Multicenter Study Open Forum Infectious Diseases. 6: S290-S290. DOI: 10.1093/Ofid/Ofz360.693  0.387
2019 Ersoy SC, Zapata-Davila B, Otmishi M, Milan V, Li L, Chambers H, Xiong Y, Bayer A. 607. Scope and Predictive Genetic/Phenotypic Signatures of “Bicarbonate [NaHCO3]-Responsivity” and β-Lactam Sensitization among Methicillin-Resistant Staphylococcus aureus (MRSA) Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.676  0.418
2019 Valderrama-Beltrán SL, Komarow L, Salcedo S, Mora L, Marin A, Ordonez Diaz KM, Cristancho Quintero E, Elena Ariza B, Cortes G, la Hoz Alejandro D, Oñate J, Yasmín Venté E, Mendez V, Figueroa J, Osorio L, ... ... Chambers H, ... ... Chambers H, et al. 2276. Clinical Epidemiology of the Carbapenem-Resistant Enterobacteriaceae (CRE) Epidemic in Colombia: A Multicenter Prospective Study Open Forum Infectious Diseases. 6: S779-S779. DOI: 10.1093/Ofid/Ofz360.1954  0.422
2018 Bystritsky R, Chambers H. Cellulitis and Soft Tissue Infections (Japanese Version). Annals of Internal Medicine. 168. PMID 32755383 DOI: 10.7326/Istranslatedfrom_Aitc201802060_Japanese  0.3
2018 Alexander JAN, Chatterjee SS, Hamilton SM, Eltis LD, Chambers HF, Strynadka NCJ. Structural and kinetic analysis of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance in . The Journal of Biological Chemistry. PMID 30366985 DOI: 10.1074/jbc.RA118.004952  0.37
2018 Evans SR, Follmann D, Liu Y, Holland T, Doernberg SB, Rouphael N, Hamasaki T, Jiang Y, Lok JJ, Tran TTT, Harris AD, Fowler VG, Boucher H, Kreiswirth BN, Bonomo RA, ... ... Chambers H, et al. Sequential Multiple Assignment Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30351426 DOI: 10.1093/Cid/Ciy912  0.353
2018 Doernberg SB, Tran TTT, Tong SYC, Paul M, Yahav D, Davis JS, Leibovici L, Boucher HW, Corey GR, Cosgrove SE, Chambers HF, Fowler VG, Evans SR, Holland TL. Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30321315 DOI: 10.1093/Cid/Ciy766  0.356
2018 Evans SR, Tran TTT, Hujer AM, Hill CB, Hujer KM, Mediavilla JR, Manca C, Domitrovic TN, Perez F, Farmer M, Pitzer KM, Wilson BM, Kreiswirth BN, Patel R, Jacobs MR, ... ... Chambers HF, et al. Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam against Pseudomonas aeruginosa: PRIMERS IV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30239599 DOI: 10.1093/Cid/Ciy801  0.406
2018 Holland TL, Chambers HF, Boucher HW, Corey GR, Coleman R, Castaneda-Ruiz B, Fowler VG. Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30202941 DOI: 10.1093/Cid/Ciy774  0.349
2018 Guimaraes AO, Cao Y, Hong K, Mayba O, Peck M, Gutierrez J, Ruffin F, Carrasco-Triguero M, Dinoso JB, Clemenzi-Allen A, Koss CA, Maskarinec S, Chambers HF, Fowler VG, Baruch A, et al. A prognostic model of persistent bacteremia and mortality in complicated S. aureus bloodstream infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30165412 DOI: 10.1093/Cid/Ciy739  0.394
2018 Doernberg SB, Abbo LM, Burdette SD, Fishman NO, Goodman EL, Kravitz GR, Leggett JE, Moehring RW, Newland JG, Robinson PA, Spivak ES, Tamma PD, Chambers HF. Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29590355 DOI: 10.1093/Cid/Ciy255  0.318
2018 Bystritsky R, Chambers H. Cellulitis and Soft Tissue Infections. Annals of Internal Medicine. 168: ITC17-ITC32. PMID 29404597 DOI: 10.7326/Aitc201802060  0.362
2018 Basuino L, Jousselin A, Alexander JAN, Strynadka NCJ, Pinho MG, Chambers HF, Chatterjee SS. PBP4 activity and its overexpression are necessary for PBP4-mediated high-level β-lactam resistance. The Journal of Antimicrobial Chemotherapy. PMID 29360990 DOI: 10.1093/Jac/Dkx531  0.405
2018 Alexander JAN, Chatterjee SS, Hamilton SM, Eltis LD, Chambers HF, Strynadka NCJ. Structural and kinetic analysis of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance inStaphylococcus aureus. Journal of Biological Chemistry. 293: 19854-19865. DOI: 10.2210/Pdb6C39/Pdb  0.485
2018 Cao Y, Guimaraes A, Hong K, Mayba O, Peck M, Gutierrez J, Ruffin F, Carrasco-Triguero M, Dinoso J, Clemenzi-Allen AA, Koss C, Maskarinec SA, Chambers HF, Fowler Jr. VG, Baruch A, et al. 1058. Prognostic Biomarkers for Persistent Bacteremia and Mortality in Complicated S. aureus Bloodstream Infection Open Forum Infectious Diseases. 5: S316-S316. DOI: 10.1093/Ofid/Ofy210.895  0.351
2018 Viau R, Wilson B, Evans SR, Perez F, Fowler VG, Chambers HF, Kreiswirth BN, Patel R, Banerjee R, Bonomo RA, Arlg. 1052. Do Healthcare Providers De-Escalate β-Lactam (BL) Antibiotic Therapy Based on Results of Antibiotic Susceptibility Testing (AST)? Analysis of Bloodstream Infections (BSI) Caused by Escherichia coli and Klebsiella pneumoniae From the Veterans Health Administration (VHA) Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.889  0.432
2018 Viau R, Wilson B, Evans SR, Perez F, Chambers HF, Fowler VG, Kreiswirth BN, Bonomo RA, Arlg. 1041. How Do Healthcare Providers Approach Empiric β-Lactam (BL) Treatment of Bloodstream Infections (BSI) Caused by Gram-Negative Rods (GNRs)? Analysis of Escherichia coli and Klebsiella pneumoniae BSI From the Veterans Health Administration (VHA) Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.878  0.382
2018 Bystritsky R, Young AT, Wong A, Hilts-Horeczko A, Macdougall C, Chambers HF, Doernberg SB. 1818. Characteristics of a Cohort of Patients on Broad-Spectrum Antibiotics Targeted for Prospective Audit and Feedback Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.1474  0.312
2018 Vaisman A, Chambers HF, Winston LG, Kazi D. 1788. Cost-Effectiveness of Penicillin Skin Testing Among Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.1444  0.337
2017 Daum RS, Kumar N, Chambers HF. A Trial of Antibiotics for Smaller Skin Abscesses. The New England Journal of Medicine. 377: e36. PMID 29281570 DOI: 10.1056/Nejmc1711124  0.305
2017 Bowen AC, Carapetis JR, Currie BJ, Fowler V, Chambers HF, Tong SYC. Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and Abscess. Open Forum Infectious Diseases. 4: ofx232. PMID 29255730 DOI: 10.1093/Ofid/Ofx232  0.401
2017 Katayama Y, Azechi T, Miyazaki M, Takata T, Sekine M, Matsui H, Hanaki H, Yahara K, Sasano H, Asakura K, Takaku T, Ochiai T, Komatsu N, Chambers HF. Prevalence of Slow-growth Vancomycin Non-susceptibility In Methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. PMID 28827421 DOI: 10.1128/Aac.00452-17  0.466
2017 Chatterjee SS, Chen L, Gilbert A, da Costa TM, Nair V, Datta SK, Kreiswirth BN, Chambers HF. PBP4 mediates β-lactam resistance by altered function. Antimicrobial Agents and Chemotherapy. PMID 28807923 DOI: 10.1128/Aac.00932-17  0.397
2017 Doernberg SB, Chambers HF. Antimicrobial Stewardship Approaches in the Intensive Care Unit. Infectious Disease Clinics of North America. PMID 28687210 DOI: 10.1016/J.Idc.2017.05.002  0.406
2017 Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. The New England Journal of Medicine. 376: 2545-2555. PMID 28657870 DOI: 10.1056/Nejmoa1607033  0.366
2017 Evans SR, Hujer AM, Jiang H, Hill CB, Hujer KM, Mediavilla JR, Manca C, Tran TTT, Domitrovic TN, Higgins PG, Seifert H, Kreiswirth BN, Patel R, Jacobs MR, Chen L, ... ... Chambers HF, et al. Correction for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III". Journal of Clinical Microbiology. 55: 1970. PMID 28536161 DOI: 10.1128/Jcm.00525-17  0.365
2017 Boucher HW, Ambrose PG, Chambers HF, Ebright RH, Jezek A, Murray BE, Newland JG, Ostrowsky B, Rex JH. White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-spectrum Indications, and Unmet Needs. The Journal of Infectious Diseases. PMID 28475768 DOI: 10.1093/Infdis/Jix211  0.449
2017 Hamilton SM, Alexander JA, Choo EJ, Basuino L, da Costa TM, Severin A, Chung M, Aedo S, Strynadka NC, Tomasz A, Chatterjee SS, Chambers HF. High-Level Resistance of Staphylococcus aureus to β-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4). Antimicrobial Agents and Chemotherapy. PMID 28373193 DOI: 10.1128/Aac.02727-16  0.447
2017 Nigo M, Diaz L, Carvajal LP, Tran TT, Rios R, Panesso D, Garavito JD, Miller WR, Wanger A, Weinstock G, Munita JM, Arias CA, Chambers HF. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis. Antimicrobial Agents and Chemotherapy. 61. PMID 28232309 DOI: 10.1128/Aac.01235-16  0.513
2017 Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, Hujer KM, Marshall EK, Rudin SD, Perez F, Wilson BM, Wasserman RB, Chikowski L, Paterson DL, Vila AJ, ... ... Chambers HF, et al. Can ceftazidime/avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae? Antimicrobial Agents and Chemotherapy. PMID 28167541 DOI: 10.1128/Aac.02243-16  0.455
2017 Strnad L, Beekmann SE, Polgreen PM, Chambers H, Liu C. Clinical Practice Variation in the Management of Staphylococcus aureus Bacteremia: Results from an Emerging Infections Network Survey Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.1438  0.347
2017 Lodise TP, Rosenkranz SL, Finnemeyer M, Huvane J, Pereira A, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, ... ... Chambers H, et al. The Emperor’s New Clothes: Prospective Observational Evaluation of the Association between the Day 2 Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE) Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx162.074  0.342
2016 Choo EJ, Chambers HF. Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Infection & Chemotherapy. 48: 267-273. PMID 28032484 DOI: 10.3947/Ic.2016.48.4.267  0.487
2016 Evans SR, Hujer AM, Jiang H, Hill CB, Hujer KM, Mediavilla JR, Manca C, Tran TT, Domitrovic TN, Higgins PG, Seifert H, Kreiswirth BN, Patel R, Jacobs MR, Chen L, ... ... Chambers HF, et al. Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics (RMDs) to Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. PRIMERS III. Journal of Clinical Microbiology. PMID 27795336 DOI: 10.1128/Jcm.01524-16  0.437
2016 Diep BA, Le VT, Badiou C, Le HN, Pinheiro MG, Duong AH, Wang X, Dip EC, Aguiar-Alves F, Basuino L, Marbach H, Mai TT, Sarda MN, Kajikawa O, Matute-Bello G, ... ... Chambers HF, et al. IVIG-mediated protection against necrotizing pneumonia caused by MRSA. Science Translational Medicine. 8: 357ra124. PMID 27655850 DOI: 10.1126/Scitranslmed.Aag1153  0.451
2016 Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E, Chambers HF, Doernberg S. Vancomycin Minimum Inhibitory Concentration Does Not Predict 90 Day Mortality, Readmission or Relapse in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia. Antimicrobial Agents and Chemotherapy. PMID 27324762 DOI: 10.1128/Aac.00658-16  0.358
2016 Pollett S, Baxi SM, Rutherford GW, Doernberg SB, Bacchetti P, Chambers HF. Cefazolin versus nafcillin for methicillin-sensitive Staphylococcus aureus bloodstream infection: an observational study in a California tertiary medical center. Antimicrobial Agents and Chemotherapy. PMID 27216053 DOI: 10.1128/Aac.00243-16  0.356
2016 Chambers HF, Basuino L, Hamilton SM, Choo EJ, Moise P. Daptomycin Plus Beta-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis. Antimicrobial Agents and Chemotherapy. PMID 27090173 DOI: 10.1128/Aac.00589-16  0.392
2016 Chan LC, Gilbert A, Basuino L, da Costa TM, Hamilton SM, Dos Santos KR, Chambers HF, Chatterjee SS. PBP4 mediates high-level resistance to new generation cephalosporins in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. PMID 27067335 DOI: 10.1128/Aac.00358-16  0.495
2016 Spellberg B, Srinivasan A, Chambers HF. New Societal Approaches to Empowering Antibiotic Stewardship. Jama. 315: 1229-30. PMID 26914942 DOI: 10.1001/Jama.2016.1346  0.419
2016 Greninger AL, Chatterjee SS, Chan LC, Hamilton SM, Chambers HF, Chiu CY. Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance. Plos One. 11: e0149541. PMID 26890675 DOI: 10.1371/Journal.Pone.0149541  0.48
2015 Evans SR, Hujer AM, Jiang H, Hujer KM, Hall T, Marzan C, Jacobs MR, Sampath R, Ecker DJ, Manca C, Chavda K, Zhang P, Fernandez H, Chen L, Mediavilla JR, ... ... Chambers HF, et al. Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26409063 DOI: 10.1093/Cid/Civ837  0.314
2015 Boyle-Vavra S, Li X, Alam MT, Read TD, Sieth J, Cywes-Bentley C, Dobbins G, David MZ, Kumar N, Eells SJ, Miller LG, Boxrud DJ, Chambers HF, Lynfield R, Lee JC, et al. USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus. Mbio. 6. PMID 25852165 DOI: 10.1128/Mbio.02585-14  0.384
2015 Chan LC, Basuino L, Dip EC, Chambers HF. Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy. 59: 3252-6. PMID 25801564 DOI: 10.1128/Aac.04376-14  0.344
2015 Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, Pettibone S, Hoagland RJ, Chambers HF. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. The New England Journal of Medicine. 372: 1093-103. PMID 25785967 DOI: 10.1056/Nejmoa1403789  0.424
2015 Chan LC, Basuino L, Diep B, Hamilton S, Chatterjee SS, Chambers HF. Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 59: 2960-3. PMID 25753637 DOI: 10.1128/Aac.05004-14  0.433
2015 Hermos CR, Shiau R, Hsiang M, Chambers HF, Pan E. Epidemiology of community-associated methicillin-resistant Staphylococcus aureus in San Francisco children Journal of Pediatric Infectious Diseases. 4: 247-259. DOI: 10.3233/Jpi-2009-0169  0.375
2015 Pollett S, Baxi S, Bacchetti P, Chambers H. Mortality Outcomes of Cefazolin Versus Nafcillin for Methicillin-Sensitive S. Aureus Blood Stream Infection: A 4-Year Prospective Cohort Study in a Californian Tertiary Medical Center Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.560  0.337
2015 Evans S, Jiang H, Hujer A, Hujer KM, Mediavilla J, Manca C, Hill C, Kreiswirth B, Patel R, Jacobs MR, Chen L, Sampath R, Hall T, Marzan C, Fowler VG, ... Chambers H, et al. Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics (RMDs) to Identify Susceptibility and Resistance to Carbapenems Against Acinetobacter spp PRIMERS –III Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1157  0.402
2014 Chambers HF. Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia. Antimicrobial Agents and Chemotherapy. 58: 7617. PMID 25392536 DOI: 10.1128/Aac.03691-14  0.492
2014 Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: e10-52. PMID 24973422 DOI: 10.1093/Cid/Ciu444  0.388
2014 Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 147-59. PMID 24947530 DOI: 10.1093/Cid/Ciu296  0.388
2014 Chambers HF. Pharmacology and the treatment of complicated skin and skin-structure infections. The New England Journal of Medicine. 370: 2238-9. PMID 24897088 DOI: 10.1056/Nejme1405078  0.376
2014 David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, et al. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 798-807. PMID 24879783 DOI: 10.1093/Cid/Ciu410  0.433
2014 Chambers HF, Bartlett JG, Bonomo RA, Chiou C, Cosgrove SE, Cross HR, Daum RS, Downing M, Evans SR, Knisely J, Kreiswirth BN, Lautenbach E, Mickley BS, Patel R, Pettigrew MM, et al. Antibacterial resistance leadership group: open for business. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1571-6. PMID 24610430 DOI: 10.1093/Cid/Ciu132  0.418
2014 Date SV, Modrusan Z, Lawrence M, Morisaki JH, Toy K, Shah IM, Kim J, Park S, Xu M, Basuino L, Chan L, Zeitschel D, Chambers HF, Tan MW, Brown EJ, et al. Global gene expression of methicillin-resistant Staphylococcus aureus USA300 during human and mouse infection. The Journal of Infectious Diseases. 209: 1542-50. PMID 24286981 DOI: 10.1093/Infdis/Jit668  0.445
2014 Dinoso JB, Gutierrez J, Choy DF, Kummerfeld S, Baruch A, Chambers HF, Rosenberger CM. Understanding heterogeneity in the host response to Staphylococcus aureus infection for prognostic biomarker discovery Critical Care. 1-53. DOI: 10.1186/Cc14017  0.433
2014 Clemenzi-Allen A, Baxi S, Gahbauer A, Imp B, Deck D, Doernberg S, Chambers HF. 727Evaluating the Impact of Socioeconomic Status on Clinical Presentation in Patients with Staphylococcus aureus Bacteremia. Open Forum Infectious Diseases. 1. DOI: 10.1093/Ofid/Ofu052.435  0.343
2014 Baxi S, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Doernberg S, Chambers HF. 724Vancomycin Minimum Inhibitory Concentration Does Not Predict Death, Recurrence or Readmission in Patients with Staphylococcus aureus Bacteremia in a Safety-Net Hospital Open Forum Infectious Diseases. 1. DOI: 10.1093/Ofid/Ofu052.432  0.314
2014 Hujer AM, Evans S, Jiang H, Hujer KM, Hall T, Marzan C, Jacobs M, Sampath R, Ecker DJ, Domitrovic TN, Manca C, Chavda K, Zhang P, Chen L, Hill C, ... ... Chambers HF, et al. 608Can Rapid Molecular Diagnostics Assist in the Choice of b-Lactam Antibiotics? An Analysis of Data from PRIMERS-II of the Antibiotic Resistance Leadership Group (ARLG) Open Forum Infectious Diseases. 1: S28-S28. DOI: 10.1093/Ofid/Ofu051.75  0.406
2014 Doi Y, Chambers HF. Other β-Lactam Antibiotics Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 293-297. DOI: 10.1016/B978-1-4557-4801-3.00022-9  0.314
2013 Diep BA, Afasizheva A, Le HN, Kajikawa O, Matute-Bello G, Tkaczyk C, Sellman B, Badiou C, Lina G, Chambers HF. Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. The Journal of Infectious Diseases. 208: 75-82. PMID 23532096 DOI: 10.1093/Infdis/Jit129  0.479
2013 Chambers HF. Cellulitis, by any other name. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1763-4. PMID 23457076 DOI: 10.1093/Cid/Cit126  0.32
2012 Hsiang MS, Shiau R, Nadle J, Chan L, Lee B, Chambers HF, Pan E. Epidemiologic Similarities in Pediatric Community-Associated Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus in the San Francisco Bay Area. Journal of the Pediatric Infectious Diseases Society. 1: 200-211. PMID 23687577 DOI: 10.1093/Jpids/Pis061  0.392
2012 Tattevin P, Schwartz BS, Graber CJ, Volinski J, Bhukhen A, Bhukhen A, Mai TT, Vo NH, Dang DN, Phan TH, Basuino L, Perdreau-Remington F, Chambers HF, Diep BA. Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 781-8. PMID 22670044 DOI: 10.1093/Cid/Cis527  0.463
2012 Doernberg SB, Winston LG, Deck DH, Chambers HF. Does doxycycline protect against development of Clostridium difficile infection? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 615-20. PMID 22563022 DOI: 10.1093/Cid/Cis457  0.434
2012 Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, Chambers HF, Tomasz A. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. Plos Pathogens. 8: e1002505. PMID 22319446 DOI: 10.1371/Journal.Ppat.1002505  0.443
2011 Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, Braughton KR, Shabb DW, Diep BA, Chambers HF, Otto M, DeLeo FR. Global changes in Staphylococcus aureus gene expression in human blood. Plos One. 6: e18617. PMID 21525981 DOI: 10.1371/Journal.Pone.0018617  0.37
2011 Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 285-92. PMID 21217178 DOI: 10.1093/cid/cir034  0.351
2011 Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: e18-55. PMID 21208910 DOI: 10.1093/Cid/Ciq146  0.455
2010 Banerjee R, Gretes M, Harlem C, Basuino L, Chambers HF. A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes. Antimicrobial Agents and Chemotherapy. 54: 4900-2. PMID 20805396 DOI: 10.1128/Aac.00594-10  0.437
2010 Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, Mai TT, Marbach H, Braughton KR, Whitney AR, Gardner DJ, Fan X, Tseng CW, Liu GY, Badiou C, ... ... Chambers HF, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proceedings of the National Academy of Sciences of the United States of America. 107: 5587-92. PMID 20231457 DOI: 10.1073/Pnas.0912403107  0.347
2010 DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 375: 1557-68. PMID 20206987 DOI: 10.1016/S0140-6736(09)61999-1  0.434
2010 Graves SF, Kobayashi SD, Braughton KR, Diep BA, Chambers HF, Otto M, Deleo FR. Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants. Microbes and Infection / Institut Pasteur. 12: 446-56. PMID 20172045 DOI: 10.1016/J.Micinf.2010.02.005  0.36
2010 Mendes RE, Sader HS, Deshpande LM, Diep BA, Chambers HF, Jones RN. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid. Journal of Clinical Microbiology. 48: 568-74. PMID 19940054 DOI: 10.1128/Jcm.01384-09  0.465
2010 Tattevin P, Basuino L, Bauer D, Diep BA, Chambers HF. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 54: 610-3. PMID 19917746 DOI: 10.1128/Aac.00886-09  0.485
2010 Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Authors' reply The Lancet. 376: 767. DOI: 10.1016/S0140-6736(10)61370-0  0.383
2009 Miragaia M, de Lencastre H, Perdreau-Remington F, Chambers HF, Higashi J, Sullam PM, Lin J, Wong KI, King KA, Otto M, Sensabaugh GF, Diep BA. Genetic diversity of arginine catabolic mobile element in Staphylococcus epidermidis. Plos One. 4: e7722. PMID 19893740 DOI: 10.1371/Journal.Pone.0007722  0.326
2009 DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. The Journal of Clinical Investigation. 119: 2464-74. PMID 19729844 DOI: 10.1172/Jci38226  0.499
2009 Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews. Microbiology. 7: 629-41. PMID 19680247 DOI: 10.1038/Nrmicro2200  0.49
2009 Winston L, Chambers H. Coming home with MRSA. Archives of Internal Medicine. 169: 1379-80. PMID 19667300 DOI: 10.1001/Archinternmed.2009.218  0.374
2009 Schwartz BS, Graber CJ, Diep BA, Basuino L, Perdreau-Remington F, Chambers HF. Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 1483-4. PMID 19374563 DOI: 10.1086/598510  0.447
2009 Tattevin P, Basuino L, Chambers HF. Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Research in Microbiology. 160: 187-92. PMID 19366630 DOI: 10.1016/J.Resmic.2009.03.003  0.471
2009 Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y, Otto M. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America. 106: 5883-8. PMID 19293374 DOI: 10.1073/Pnas.0900743106  0.421
2009 Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 713-21. PMID 19207079 DOI: 10.1086/597031  0.342
2009 Chambers HF, Basuino L, Diep BA, Steenbergen J, Zhang S, Tattevin P, Alder J. Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis. Antimicrobial Agents and Chemotherapy. 53: 1463-7. PMID 19171803 DOI: 10.1128/Aac.01307-08  0.35
2009 Chambers HF. Pathogenesis of staphylococcal infection: a manner of expression. The Journal of Infectious Diseases. 199: 291-3. PMID 19115950 DOI: 10.1086/595983  0.336
2008 Graber CJ, Jacobson MA, Perdreau-Remington F, Chambers HF, Diep BA. Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 231-3. PMID 18820536 DOI: 10.1097/Qai.0B013E318183A947  0.399
2008 Diep BA, Palazzolo-Ballance AM, Tattevin P, Basuino L, Braughton KR, Whitney AR, Chen L, Kreiswirth BN, Otto M, DeLeo FR, Chambers HF. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Plos One. 3: e3198. PMID 18787708 DOI: 10.1371/Journal.Pone.0003198  0.427
2008 Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages SA, Jones A, Palazzolo-Ballance AM, Perdreau-Remington F, Sensabaugh GF, DeLeo FR, Chambers HF. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. The Journal of Infectious Diseases. 197: 1523-30. PMID 18700257 DOI: 10.1086/587907  0.448
2008 Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Archives of Internal Medicine. 168: 1585-91. PMID 18663172 DOI: 10.1001/Archinte.168.14.1585  0.37
2008 Xiong YQ, Bensing BA, Bayer AS, Chambers HF, Sullam PM. Role of the serine-rich surface glycoprotein GspB of Streptococcus gordonii in the pathogenesis of infective endocarditis. Microbial Pathogenesis. 45: 297-301. PMID 18656529 DOI: 10.1016/J.Micpath.2008.06.004  0.333
2008 Stryjewski ME, Chambers HF. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: S368-77. PMID 18462092 DOI: 10.1086/533593  0.47
2008 Liu C, Graber CJ, Karr M, Diep BA, Basuino L, Schwartz BS, Enright MC, O'Hanlon SJ, Thomas JC, Perdreau-Remington F, Gordon S, Gunthorpe H, Jacobs R, Jensen P, Leoung G, ... ... Chambers HF, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1637-46. PMID 18433335 DOI: 10.1086/587893  0.437
2008 Banerjee R, Gretes M, Basuino L, Strynadka N, Chambers HF. In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 52: 2089-96. PMID 18378703 DOI: 10.1128/Aac.01403-07  0.452
2008 Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL, Chen JH, Lin F, Lin J, Phan TH, Carleton HA, McDougal LK, Tenover FC, Cohen DE, Mayer KH, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Annals of Internal Medicine. 148: 249-57. PMID 18283202 DOI: 10.7326/0003-4819-148-4-200802190-00204  0.474
2008 David MZ, Siegel JD, Chambers HF, Daum RS. Determining whether methicillin-resistant Staphylococcus aureus is associated with health care. Jama. 299: 519; author reply 51. PMID 18252879 DOI: 10.1001/Jama.299.5.519-A  0.395
2007 Rajendran PM, Young D, Maurer T, Chambers H, Perdreau-Remington F, Ro P, Harris H. Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection Antimicrobial Agents and Chemotherapy. 51: 4044-4048. PMID 17846141 DOI: 10.1128/Aac.00377-07  0.462
2007 Graber CJ, Wong MK, Carleton HA, Perdreau-Remington F, Haller BL, Chambers HF. Intermediate vancomycin susceptibility in a community-associated MRSA clone. Emerging Infectious Diseases. 13: 491-3. PMID 17552110 DOI: 10.3201/Eid1303.060960  0.446
2007 Chambers HF, Hegde SS. Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin? Expert Review of Anti-Infective Therapy. 5: 333-5. PMID 17547497 DOI: 10.1586/14787210.5.3.333  0.474
2006 Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. The New England Journal of Medicine. 355: 653-65. PMID 16914701 DOI: 10.1056/Nejmoa053783  0.368
2006 Rutar T, Chambers HF, Crawford JB, Perdreau-Remington F, Zwick OM, Karr M, Diehn JJ, Cockerham KP. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology. 113: 1455-62. PMID 16766029 DOI: 10.1016/J.Ophtha.2006.03.031  0.435
2006 Chambers HF. Ceftobiprole: in-vivo profile of a bactericidal cephalosporin. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 12: 17-22. PMID 16524424 DOI: 10.1111/J.1469-0691.2006.01404.X  0.473
2006 Rajendran PM, Young D, Maurer T, Chambers H, Harris H. Treatment of abscesses in the era of methicillin resistant staphylococcus aureus–Are antibiotics necessary? Journal of the American College of Surgeons. 203. DOI: 10.1016/J.Jamcollsurg.2006.05.152  0.474
2005 Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 1373-406. PMID 16231249 DOI: 10.1086/497143  0.317
2005 Madrigal AG, Basuino L, Chambers HF. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 49: 3163-5. PMID 16048918 DOI: 10.1128/Aac.49.8.3163-3165.2005  0.449
2005 Chambers HF, Turner J, Schecter GF, Kawamura M, Hopewell PC. Imipenem for treatment of tuberculosis in mice and humans. Antimicrobial Agents and Chemotherapy. 49: 2816-21. PMID 15980354 DOI: 10.1128/Aac.49.7.2816-2821.2005  0.34
2005 Eguia JM, Liu C, Moore M, Wrone EM, Pont J, Gerberding JL, Chambers HF. Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 1617-24. PMID 15889359 DOI: 10.1086/429906  0.497
2005 Katayama Y, Robinson DA, Enright MC, Chambers HF. Genetic background affects stability of mecA in Staphylococcus aureus. Journal of Clinical Microbiology. 43: 2380-3. PMID 15872270 DOI: 10.1128/Jcm.43.5.2380-2383.2005  0.441
2005 Chambers HF. Staphylococcal purpura fulminans: a toxin-mediated disease? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 948-50. PMID 15824984 DOI: 10.1086/428584  0.405
2005 Chambers HF. Community-associated MRSA--resistance and virulence converge. The New England Journal of Medicine. 352: 1485-7. PMID 15814886 DOI: 10.1056/Nejme058023  0.486
2005 Siboo IR, Chambers HF, Sullam PM. Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infection and Immunity. 73: 2273-80. PMID 15784571 DOI: 10.1128/Iai.73.4.2273-2280.2005  0.319
2005 Chambers HF. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 49: 884-8. PMID 15728879 DOI: 10.1128/Aac.49.3.884-888.2005  0.502
2004 Winston LG, Charlebois ED, Pang S, Bangsberg DR, Perdreau-Remington F, Chambers HF. Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci. American Journal of Infection Control. 32: 462-9. PMID 15573053 DOI: 10.1016/J.Ajic.2004.07.004  0.401
2004 Young DM, Harris HW, Charlebois ED, Chambers H, Campbell A, Perdreau-Remington F, Lee C, Mankani M, Mackersie R, Schecter WP. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Archives of Surgery (Chicago, Ill. : 1960). 139: 947-51; discussion 9. PMID 15381611 DOI: 10.1001/Archsurg.139.9.947  0.477
2004 Wilke MS, Hills TL, Zhang HZ, Chambers HF, Strynadka NC. Crystal structures of the Apo and penicillin-acylated forms of the BlaR1 beta-lactam sensor of Staphylococcus aureus. The Journal of Biological Chemistry. 279: 47278-87. PMID 15322076 DOI: 10.1074/Jbc.M407054200  0.363
2004 Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, Ng VL, Chansky K, Edlin BR, Edlin B, Chambers HF. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 47-54. PMID 15206052 DOI: 10.1086/421090  0.441
2004 Winston LG, Pang S, Haller BL, Wong M, Chambers HF, Perdreau-Remington F. API 20 strep identification system may incorrectly speciate enterococci with low level resistance to vancomycin. Diagnostic Microbiology and Infectious Disease. 48: 287-8. PMID 15062923 DOI: 10.1016/J.Diagmicrobio.2003.10.008  0.429
2004 Carpenter CF, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: 994-1000. PMID 15034832 DOI: 10.1086/383472  0.333
2004 Katayama Y, Zhang HZ, Chambers HF. PBP 2a mutations producing very-high-level resistance to beta-lactams. Antimicrobial Agents and Chemotherapy. 48: 453-9. PMID 14742194 DOI: 10.1128/Aac.48.2.453-459.2004  0.371
2003 Eguia JM, Chambers HF. Methicillin-resistant staphylococci and their treatment in the intensive care unit. Seminars in Respiratory and Critical Care Medicine. 24: 37-48. PMID 16088523 DOI: 10.1055/S-2003-37915  0.509
2003 Katayama Y, Zhang HZ, Chambers HF. Effect of disruption of Staphylococcus aureus PBP4 gene on resistance to beta-lactam antibiotics. Microbial Drug Resistance (Larchmont, N.Y.). 9: 329-36. PMID 15000739 DOI: 10.1089/107662903322762752  0.479
2003 Eguia JM, Chambers HF. Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors. Current Infectious Disease Reports. 5: 459-466. PMID 14642185 DOI: 10.1007/S11908-003-0087-6  0.442
2003 Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrobial Agents and Chemotherapy. 47: 3040-5. PMID 14506006 DOI: 10.1128/Aac.47.10.3040-3045.2003  0.493
2003 Katayama Y, Zhang HZ, Hong D, Chambers HF. Jumping the barrier to beta-lactam resistance in Staphylococcus aureus. Journal of Bacteriology. 185: 5465-72. PMID 12949098 DOI: 10.1128/Jb.185.18.5465-5472.2003  0.427
2003 Chambers HF. Solving staphylococcal resistance to beta-lactams. Trends in Microbiology. 11: 145-8. PMID 12706985 DOI: 10.1016/S0966-842X(03)00046-5  0.399
2003 Moore MR, Perdreau-Remington F, Chambers HF. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrobial Agents and Chemotherapy. 47: 1262-6. PMID 12654656 DOI: 10.1128/Aac.47.4.1262-1266.2003  0.503
2002 Winston LG, Bangsberg DR, Chambers HF, Felt SC, Rosen JI, Charlebois ED, Wong M, Steele L, Gerberding JL, Perdreau-Remington F. Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital. American Journal of Infection Control. 30: 400-6. PMID 12410216 DOI: 10.1067/Mic.2002.122647  0.426
2002 Charlebois ED, Bangsberg DR, Moss NJ, Moore MR, Moss AR, Chambers HF, Perdreau-Remington F. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 425-33. PMID 11797167 DOI: 10.1086/338069  0.483
2001 Chambers HF. Methicillin-resistant Staphylococcus aureus. Mechanisms of resistance and implications for treatment. Postgraduate Medicine. 109: 43-50. PMID 19667557 DOI: 10.3810/pgm.02.2001.suppl12.65  0.354
2001 Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases. 7: 178-82. PMID 11294701 DOI: 10.3201/Eid0702.010204  0.436
2000 Luchi M, Morrison DC, Opal S, Yoneda K, Slotman G, Chambers H, Wiesenfeld H, Lemke J, Ryan JL, Horn D. A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsis Journal of Endotoxin Research. 6: 25-31. PMID 11061029 DOI: 10.1177/09680519000060010401  0.351
1999 Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 43: 2742-6. PMID 10543757 DOI: 10.1128/Aac.43.11.2742  0.499
1999 Martin JN, Perdreau-Remington F, Kartalija M, Pasi OG, Webb M, Gerberding JL, Chambers HF, Täuber MG, Lee BL. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. The Journal of Infectious Diseases. 180: 896-9. PMID 10438389 DOI: 10.1086/314949  0.403
1999 Chambers HF. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. The Journal of Infectious Diseases. 179: S353-9. PMID 10081507 DOI: 10.1086/513854  0.453
1998 Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, Levison M, Chambers HF, Dajani AS, Gewitz MH, Newburger JW, Gerber MA, Shulman ST, Pallasch TJ, Gage TW, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 98: 2936-48. PMID 9860802 DOI: 10.1161/01.Cir.98.25.2936  0.338
1998 Kim YS, Liu Q, Chow LL, Chambers HF, Täuber MG. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 42: 3325-7. PMID 9835540 DOI: 10.1128/Aac.42.12.3325  0.473
1998 Perdreau-Remington F, Sande MA, Peters G, Chambers HF. The abilities of a Staphylococcus epidermidis wild-type strain and its slime-negative mutant to induce endocarditis in rabbits are comparable. Infection and Immunity. 66: 2778-81. PMID 9596747 DOI: 10.1128/Iai.66.6.2778-2781.1998  0.344
1998 Chambers HF, Kocagöz T, Sipit T, Turner J, Hopewell PC. Activity of amoxicillin/clavulanate in patients with tuberculosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 26: 874-7. PMID 9564467 DOI: 10.1086/513945  0.326
1997 Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clinical Microbiology Reviews. 10: 781-91. PMID 9336672 DOI: 10.1128/Cmr.10.4.781  0.481
1997 Hackbarth CJ, Unsal I, Chambers HF. Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra. Antimicrobial Agents and Chemotherapy. 41: 1182-5. PMID 9145897 DOI: 10.1128/Aac.41.5.1182  0.323
1996 Kocagöz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrobial Agents and Chemotherapy. 40: 1768-74. PMID 8843279 DOI: 10.1128/Aac.40.8.1768  0.335
1996 Frank U, Chambers HF. Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit model. Antimicrobial Agents and Chemotherapy. 40: 1308-10. PMID 8723492 DOI: 10.1128/Aac.40.5.1308  0.394
1995 Chambers HF, Moreau D, Yajko D, Miick C, Wagner C, Hackbarth C, Kocagöz S, Rosenberg E, Hadley WK, Nikaido H. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrobial Agents and Chemotherapy. 39: 2620-4. PMID 8592990 DOI: 10.1128/Aac.39.12.2620  0.364
1995 Chambers HF. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a. Antimicrobial Agents and Chemotherapy. 39: 462-6. PMID 7726516 DOI: 10.1128/Aac.39.2.462  0.435
1995 Chambers HF, Kartalija M, Sande M. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. The Journal of Infectious Diseases. 171: 897-902. PMID 7706817 DOI: 10.1093/Infdis/171.4.897  0.452
1995 Hackbarth CJ, Kocagoz T, Kocagoz S, Chambers HF. Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance. Antimicrobial Agents and Chemotherapy. 39: 103-6. PMID 7695289 DOI: 10.1128/Aac.39.1.103  0.438
1994 Chambers HF, Sachdeva MJ, Hackbarth CJ. Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus. The Biochemical Journal. 301: 139-44. PMID 8037661 DOI: 10.1042/Bj3010139  0.44
1994 Hackbarth CJ, Miick C, Chambers HF. Altered production of penicillin-binding protein 2a can affect phenotypic expression of methicillin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 38: 2568-71. PMID 7872749 DOI: 10.1128/Aac.38.11.2568  0.417
1993 Hackbarth CJ, Chambers HF. blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 37: 1144-9. PMID 8517704 DOI: 10.1128/Aac.37.5.1144  0.317
1993 Chambers HF. Detection of methicillin-resistant staphylococci. Infectious Disease Clinics of North America. 7: 425-33. PMID 8345177  0.3
1993 Chambers HF, Fournier MA. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits. The Journal of Antimicrobial Chemotherapy. 32: 453-8. PMID 8262867 DOI: 10.1093/Jac/32.3.453  0.457
1992 Chambers HF, Miick C. Characterization of penicillin-binding protein 2 of Staphylococcus aureus: deacylation reaction and identification of two penicillin-binding peptides. Antimicrobial Agents and Chemotherapy. 36: 656-61. PMID 1622180 DOI: 10.1128/Aac.36.3.656  0.336
1992 Chambers HF. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus. The Journal of Antimicrobial Chemotherapy. 30: 117-22. PMID 1399943 DOI: 10.1093/Jac/30.Suppl_A.117  0.453
1991 Chambers HF. Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology. 12: 29-35. PMID 1847961 DOI: 10.1086/646235  0.521
1991 Gerberding JL, Miick C, Liu HH, Chambers HF. Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 35: 2574-9. PMID 1810191 DOI: 10.1128/Aac.35.12.2574  0.375
1991 Barg N, Chambers H, Kernodle D. Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of beta-lactamase. Antimicrobial Agents and Chemotherapy. 35: 1975-1979. PMID 1759816 DOI: 10.1128/Aac.35.10.1975  0.358
1991 Lee BL, Sachdeva M, Chambers HF. Effect of protein binding of daptomycin on MIC and antibacterial activity. Antimicrobial Agents and Chemotherapy. 35: 2505-8. PMID 1667253 DOI: 10.1128/Aac.35.12.2505  0.303
1990 Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrobial Agents and Chemotherapy. 34: 1227-31. PMID 2393284 DOI: 10.1128/Aac.34.6.1227  0.426
1990 Chambers HF, Sachdeva M, Kennedy S. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus. The Journal of Infectious Diseases. 162: 705-10. PMID 2387996 DOI: 10.1093/Infdis/162.3.705  0.462
1990 Chambers HF, Sachdeva M. Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. The Journal of Infectious Diseases. 161: 1170-6. PMID 2345297 DOI: 10.1093/Infdis/161.6.1170  0.448
1990 Stratton CW, Gelfand MS, Gerberding JL, Chambers HF. Characterization of mechanisms of resistance to beta-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus. Antimicrobial Agents and Chemotherapy. 34: 1780-2. PMID 2285290 DOI: 10.1128/Aac.34.9.1780  0.462
1990 Chambers HF, Kennedy S. Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrobial Agents and Chemotherapy. 34: 510-4. PMID 2140496 DOI: 10.1128/Aac.34.4.510  0.311
1989 Chambers HF, Archer G, Matsuhashi M. Low-level methicillin resistance in strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 33: 424-8. PMID 2729937 DOI: 10.1128/Aac.33.4.424  0.494
1989 Hackbarth CJ, Chambers HF. Methicillin-resistant staphylococci: detection methods and treatment of infections. Antimicrobial Agents and Chemotherapy. 33: 995-9. PMID 2675760 DOI: 10.1128/Aac.33.7.995  0.44
1989 Hackbarth CJ, Chambers HF. Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrobial Agents and Chemotherapy. 33: 991-4. PMID 2675759 DOI: 10.1128/Aac.33.7.991  0.411
1989 Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet. 2: 1071-3. PMID 2572799 DOI: 10.1016/S0140-6736(89)91083-0  0.317
1989 Kennedy S, Chambers HF. Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits. Antimicrobial Agents and Chemotherapy. 33: 1522-5. PMID 2554799 DOI: 10.1128/Aac.33.9.1522  0.366
1988 Jacobson MA, Gellermann H, Chambers H. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. The American Journal of Medicine. 85: 172-176. PMID 3400693 DOI: 10.1016/S0002-9343(88)80337-1  0.391
1988 Chambers HF. Methicillin-resistant staphylococci. Clinical Microbiology Reviews. 1: 173-86. PMID 3069195 DOI: 10.1128/Cmr.1.2.173  0.495
1987 Chambers HF, Miller MH. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits. The Journal of Infectious Diseases. 155: 581-5. PMID 3643249 DOI: 10.1093/Infdis/155.3.581  0.496
1987 Sachdeva M, Hackbarth C, Stella FB, Chambers HF. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy. 31: 1549-52. PMID 3481245 DOI: 10.1128/Aac.31.10.1549  0.486
1987 Chambers HF, Hackbarth CJ. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 31: 1982-8. PMID 3439805 DOI: 10.1128/Aac.31.12.1982  0.405
1987 Chambers HF. Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a. Antimicrobial Agents and Chemotherapy. 31: 1919-24. PMID 3439802 DOI: 10.1128/Aac.31.12.1919  0.453
1986 Hackbarth CJ, Chambers HF, Sande MA. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 29: 611-3. PMID 3707110 DOI: 10.1128/Aac.29.4.611  0.441
1986 Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 30: 382-4. PMID 3640590 DOI: 10.1128/Aac.30.3.382  0.483
1986 Hackbarth CJ, Chambers HF, Stella F, Shibl AM, Sande MA. Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. The Journal of Antimicrobial Chemotherapy. 18: 65-9. PMID 3100492 DOI: 10.1093/Jac/18.Supplement_D.65  0.307
1985 Chambers HF, Hartman BJ, Tomasz A. Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin. The Journal of Clinical Investigation. 76: 325-31. PMID 4019783 DOI: 10.1172/Jci111965  0.449
1985 Sullam PM, Täuber MG, Hackbarth CJ, Chambers HF, Scott KG, Sande MA. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 27: 685-7. PMID 3860185 DOI: 10.1128/Aac.27.5.685  0.508
1984 Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. The Journal of Infectious Diseases. 149: 894-903. PMID 6564133 DOI: 10.1093/Infdis/149.6.894  0.494
1984 Chambers HF, Mills J, Drake TA, Sande MA. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Reviews of Infectious Diseases. 6: S870-4. PMID 6522927 DOI: 10.1093/Clinids/6.Supplement_4.S870  0.433
1984 Chambers HF, Sande MA. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 26: 61-4. PMID 6236747 DOI: 10.1128/Aac.26.1.61  0.516
1983 Chambers HF, Korzeniowski OM, Sande MA. Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine. 62: 170-7. PMID 6843356 DOI: 10.1097/00005792-198305000-00004  0.327
Show low-probability matches.